Business
from24/7 Wall St.
2 days agoThe $15B Nuclear Bet With Zero Revenue Looks Safer Than the One Actually Selling
Oklo remains pre-revenue with substantial cash runway while NuScale faces massive one-time charges, dilution, and a severe earnings miss despite a TVA win.